AZN Investors have Opportunity to Lead AstraZeneca PLC Securities Fraud lawsuit

Lawsuit Details - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of AstraZeneca PLC securities between February 23, 2022, and December 17, 2024 [1] - The lawsuit alleges that AstraZeneca made materially false and/or misleading statements and/or failed to disclose key information during the Class Period [3] - The allegations include AstraZeneca engaging in insurance fraud in China, leading to heightened legal exposure and the detention of the AstraZeneca China President by Chinese authorities [3] - The lawsuit claims that AstraZeneca understated its legal risks and that the revelations could materially harm its business activities in China [3] - Investors allegedly suffered damages when the true details entered the market [3] Legal Process - A class action lawsuit has already been filed, and potential lead plaintiffs must move the Court no later than February 21, 2025 [1][2] - No class has been certified yet, and investors are not represented by counsel unless they retain one [4] - Investors may select their own counsel or remain absent class members without taking action [4] - The ability to share in any potential future recovery is not dependent upon serving as lead plaintiff [4] Compensation and Fees - Investors who purchased AstraZeneca securities during the Class Period may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement [7] Rosen Law Firm Background - Rosen Law Firm specializes in securities class actions and shareholder derivative litigation, representing investors globally [8] - The firm achieved the largest ever securities class action settlement against a Chinese company at the time [8] - Ranked No 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and consistently ranked in the top 4 since 2013 [8] - Recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [8] - Founding partner Laurence Rosen was named a Titan of Plaintiffs' Bar by Law360 in 2020 [8] Contact Information - Investors can join the AstraZeneca class action by visiting the Rosen Law Firm website or contacting Phillip Kim, Esq toll-free at 866-767-3653 or via email [2][9][12] - Updates on the case can be followed on LinkedIn, Twitter, and Facebook [10]